Neurological Disease
A Wealth of Information
on the Brain
Kinarm can provide objective measures of motor decline, cognitive impairment and loss of inhibitory control currently missing in gold standard assessments.
Better Your Research with Kinarm
Quantify Loss of Inhibitory Control
Inhibitory control can be quantified to help improve motor function.
Measure With Accuracy
Simultaneously measure motor performance (bradykinesia) and response inhibition.
Screen Quickly and Easily.
Rapidly screen for preoperative deficits in inhibitory control.
Help Subjects Recover.
Titrate STN-DBS to maximize the therapeutic benefits on movement, and minimize impaired inhibitory control.
Rapid Screening.
This can be useful in discovering early symptoms of mild cognitive impairment or familial Alzheimer’s.
Articles & Case Studies
Kinarm News
Cerebellar Damage and Proprioception
- June 12, 2019
Relevant Publications
Tamilselvam YK, Jog MS, Patel RV. (2023)
IEEE Trans Neural Syst Rehabil Eng. 2023;31:3201-3211. doi: 10.1109/TNSRE.2023.3299884. Epub 2023 Aug 9.
Goldlist S, Wijeyaratnam DO, Edwards T, Pilutti LA, Cressman EK. (2022)
Mult Scler J Exp Transl Clin. 2022 Jul 5;8(3):20552173221111761. doi: 10.1177/20552173221111761.
Gaprielian P, Scott SH, Levy R. (2022)
Parkinsons Dis. 2022 Mar 28;2022:8132923. doi: 10.1155/2022/8132923.
Zimmet AM, Cao D, Bastian AJ, Cowan NJ. (2020)
Elife. 2020 Oct 7;9:e53246. doi: 10.7554/eLife.53246. PMID: 33025903; PMCID: PMC7577735.
